The Timed 25-Foot Walk is a practical measure of ambulation in multiple sclerosis, with key times indicating disability landmarks.
The Timed 25-Foot Walk (T25FW) is a popular measure of multiple sclerosis (MS) ambulatory function, but its clinical meaningfulness has not been established. Investigators examined the relationship of the T25FW within the MS population to activities of daily living (ADLs), disability, and mobility.
For initial benchmark development, this cross-sectional study first collected questionnaires from about 160 patients on employment, instrumental ADLs, walking devices, and patient-reported outcomes. Next, an additional 95 patients were used as a validation cohort.
Significant differences in clinical outcomes were seen with walking thresholds of 6 and 8 seconds (s). Categorizing normal to mildly impaired as times <6.0 s, moderately impaired as 6.0 t…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)